Sicor de Mexico

Sicor de Mexico, located near Toluca, Mexico, specializes in the production of highly potent active pharmaceutical ingredients. This is a highly specialized facility with expertise in the production of high volume steroids, steroidal cancer products and platinum derived cancer compounds. The API’s produced at this facility are primarily used in injectable, inhalation, nasal and topical formulations. The plant has in-house capabilities for customized particle size distribution. Sicor De México, S.A. De C.V. specializes in the production of pharmaceutical ingredients with expertise in the production of steroids, steroidal cancer products and platinum derived cancer compounds. The company was founded in 1983 and is based in Lerma, Mexico. Sicor De México, S.A. De C.V. operates as a subsidiary of SICOR, Inc. SICOR, Inc. manufactures and markets generic injectable pharmaceutical products, active pharmaceutical ingredients (API), and generic biopharmaceuticals. The companys products include anti-inflammatories, antibiotics, oncolytics, analgesic, immunosuppressants, neuromuscular blocking agents, and muscle relaxants. SICOR, Inc. was forrmerly known as Gensia Sicor, Inc. and changed its name to SICOR, Inc. in June 1999. The company was founded in 1986 and is based in Irvine, California. As of January 22, 2004, SICOR, Inc. operates as a subsidiary of Teva Pharmaceutical Industries Limited.